Accord Healthcare, Inc. has issued a consumer-level, nationwide recall of a single lot (PW05264) of mislabeled hydrochlorothiazide 12.5 mg tablets, per U.S. Food and Drug Administration (FDA). It was discovered, through a patient complaint, that a 100-count bottle hydrochlorothiazide contains 100 spironolactone 25 mg tablets.
Similar to hydrochlorothiazide, spironolactone is also used as a blood pressure drug. However, the use of spironolactone could increase potassium levels, which could be fatal for some patients. It could even cause arrhythmia when taken in larger doses. It is also used to treat liver, heart and kidney failure, according to the FDA. Aldactone and CaroSpir are the brand names that spironolactone is sold in, per NBC News.
As of now, there are no reports of patients getting sick because of this mishap.
Accord believes that no other lots of hydrochlorothiazide have been affected by the mislabeling, however, it asks consumers to be more cautious especially if this drug is prescribed to them. The company also calls for wholesalers and distributors to halt the distribution of this drug and immediately notify their customers.
For guidance, FDA also included this description of the drug in its announcement: “Accord’s Hydrochlorothiazide Tablets USP 12.5 mg are light orange to peach colored, round, biconvex tablets debossed with H on one side and 1 on another side.”
Accord also encourages both consumers and distributors to contact them about this recall during business hours—Monday through Friday 8 a.m. to 5 p.m. EST. You can reach them by:
- phone: at 1-855-869-1081
- fax: 1-817-868-5362
- e-mail: email@example.com
Accord Healthcare, Inc. is a generic pharmaceutical company that develops and manufactures products for different areas of medicine. It serves consumers from North America, Europe, South America, Australia, New Zealand, South Africa and the MENA region.
IoT and LaaS mean stronger growth for LED market
With the advent of the Internet of Things and Lighting-as-a-Service, LED lighting is growing even more popular as it becomes...
Disney continues the quest to buy Fox as Brazilian regulators raise concerns
Brazil is the latest country from which Disney must seek regulatory approval to purchase 21st Century Fox and form New...
Why consumers should care about the launch of 5G
5G has started to roll out, but many consumers are not excited about it given the poor and unreliable cellular...
Self-Directed IRA LLC: How to know it’s right for you
You can use a Self-Directed IRA LLC to diversify your retirement portfolio, especially when you want to invest in assets...
GlaxoSmithKline to acquire Tesaro to strengthen pharmaceuticals business
GlaxoSmithKline is beefing up its pharmaceuticals business with the acquisition of Tesaro for its strength in cancer treatment drugs, and...
Collections5 days ago
Snyder art gallery in Texas showcases creativity at its smallest
Featured4 days ago
Cannabis companies look towards global production as North American pot stocks suffer heavy losses
Crypto3 days ago
Kaleido’s Blockchain-as-a-Service offers enterprise subscriptions
Base Metals4 days ago
Going beyond gold: Companies eye Nevada as base metals center
Crypto3 days ago
Is Bitcoin entering a mining death spiral?
Crypto4 days ago
G20 leaders agree to regulate crypto-assets but no mention of taxation
Entrepreneurship3 days ago
Why website owners should have good page loading speed
Agriculture3 days ago
US agriculture futures surge following news of trade war truce with China